mtDNA in the Pathogenesis of Cardiovascular Diseases

Area of Science:

• Cardiovascular Medicine
• Mitochondrial Biology
• Genetics

Background:

• Cardiovascular disease (CVD) incidence and mortality are increasing globally.
• Mitochondrial DNA (mtDNA) is increasingly recognized for its role in CVD pathogenesis, particularly heart failure and ischemic heart diseases.
• Current research highlights mtDNA copy number as a biomarker for mitochondrial dysfunction in CVD, exploring mechanisms like mtDNA autophagy, inflammation, and metabolic alterations.

Purpose of the Study:

• To comprehensively review the current understanding of how mitochondrial DNA (mtDNA) influences the occurrence, development, and prognosis of cardiovascular diseases (CVD).
• To identify common mechanisms or correlations between different mtDNA-related pathways in CVD pathogenesis.
• To consolidate existing research on mtDNA's role in CVD for future therapeutic strategies.

Main Methods:

• Literature review of current research on mitochondrial DNA and cardiovascular disease.
• Analysis of studies focusing on mtDNA copy number, autophagy, inflammation, and metabolic functions in CVD.
• Synthesis of findings to identify commonalities and correlations in mtDNA-related CVD mechanisms.

Main Results:

• Mitochondrial DNA (mtDNA) copy number is a key factor in CVD development.
• Mechanisms such as mtDNA autophagy, cardiac inflammation, and metabolic dysfunction are significantly influenced by mtDNA.
• Evidence suggests interconnectedness between these mtDNA-related pathways in CVD progression.

Conclusions:

• Mitochondrial DNA (mtDNA) plays a critical and multifaceted role in the pathogenesis and progression of cardiovascular diseases (CVD).
• Understanding the common mechanisms and correlations among mtDNA-related pathways is crucial for developing effective CVD treatments.
• Further research into mtDNA's influence on CVD is warranted to explore its full therapeutic potential.